Applied Therapeutics, Inc.

NASDAQ:APLT

0.86 (USD) • At close December 31, 2024
Bedrijfsnaam Applied Therapeutics, Inc.
Symbool APLT
Munteenheid USD
Prijs 0.856
Beurswaarde 99,624,007
Dividendpercentage 0%
52-weken bereik 0.773 - 10.624
Industrie Biotechnology
Sector Healthcare
CEO Dr. Shoshana Shendelman Ph.D.
Website https://www.appliedtherapeutics.com

An error occurred while fetching data.

Over Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment

Vergelijkbare Aandelen

Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

MBRX

1.7 USD

Evogene Ltd. logo

Evogene Ltd.

EVGN

1.87 USD

Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.

COCP

2.02 USD

AVROBIO, Inc. logo

AVROBIO, Inc.

AVRO

1.4 USD

Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

TPST

0.835 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

5.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)